Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Drugs Made In America Acquisition (DMAA) Cash from Operations (2025)

Drugs Made In America Acquisition filings provide 1 years of Cash from Operations readings, the most recent being 125180.0 for Q4 2025.

  • Quarterly Cash from Operations changed N/A to 125180.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 539187.0 through Dec 2025, changed N/A year-over-year, with the annual reading at 539187.0 for FY2025, 213.0% down from the prior year.
  • Cash from Operations hit 125180.0 in Q4 2025 for Drugs Made In America Acquisition, down from 56108.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 56108.0 in Q3 2025 and bottomed at 251244.0 in Q1 2025.